Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Sales (2020 - 2025)

Celularity (CELU) has disclosed Return on Sales for 6 consecutive years, with 4.37% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales fell 264.0% to 4.37% in Q3 2025 year-over-year; TTM through Sep 2025 was 3.49%, a 276.0% decrease, with the full-year FY2024 number at 1.07%, up 755.0% from a year prior.
  • Return on Sales was 4.37% for Q3 2025 at Celularity, down from 4.28% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 12.67% in Q2 2022 to a low of 30.64% in Q1 2021.
  • A 5-year average of 6.73% and a median of 1.73% in 2024 define the central range for Return on Sales.
  • Biggest YoY gain for Return on Sales was 6659bps in 2021; the steepest drop was -5400bps in 2021.
  • Celularity's Return on Sales stood at 0.83% in 2021, then surged by 812bps to 5.92% in 2022, then crashed by -87bps to 0.79% in 2023, then crashed by -2551bps to 19.32% in 2024, then surged by 77bps to 4.37% in 2025.
  • Per Business Quant, the three most recent readings for CELU's Return on Sales are 4.37% (Q3 2025), 4.28% (Q2 2025), and 1.73% (Q1 2025).